drugset
drugset / Trial / NCT05470387

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

NCT05470387 ↗

Phase 3 Terminated 23 enrolled Palisade Bio
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of LB1148 in subjects undergoing planned bowel resection.

Timeline

Start
2022-06-28
Primary completion
2023-03-06
Completion
2023-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 700 ml Oral

Indications

ileus